Anti-PD-1 antibodies
US12122834B2 · kind B2 · utility
0Cited by
19References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2019 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Jan 18, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-PD-1 antibodies and antigen-binding fragments, and use of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.